Protein Expression of NEK2, JMJD4, and REST in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical, Pathological, and Prognostic Findings

BACKGROUND & OBJECTIVE: Cells of renal cell carcinoma (RCC) are resistant to the most currently used chemotherapeutic agents and targeted therapies; hence, we evaluated the expression of NEK2, JMJD4, and REST in cases of clear cell renal cell carcinoma (ccRCC) and benign adjacent tissues of kidn...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsayed, Walid S H, Harb, Ola A, Alabiad, Mohamed Ali, Faraj Saad, Rema H, Anbaig, Amal, Alorini, Mohammed, Hemeda, Rehab, Negm, Mohamed, Gertallah, Loay M, Abdelhady, Waleed A, Ali, Ramadan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Pathology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439757/
https://www.ncbi.nlm.nih.gov/pubmed/37600577
http://dx.doi.org/10.30699/IJP.2023.1974154.3022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439757/
https://www.ncbi.nlm.nih.gov/pubmed/37600577
http://dx.doi.org/10.30699/IJP.2023.1974154.3022

Ejemplares similares